https://www.selleckchem.com/TGF-beta.html
Phacoemulsification is the accepted first-line treatment for cataracts. This study aims to explore the changes in visual function and quality of life in patients with senile cataracts following phacoemulsification, and its risk factors. The clinical data of 104 patients (202 eyes in total) with senile cataract who underwent phacoemulsification in our hospital from August 2017 to August 2019 were retrospectively analyzed, and finally 102 cases (198 eyes) were enrolled according to the inclusion and exclusion criteria. These eyes were divided int
Mi piace
Commento
Condividi
